MiR-135b-5p is an Oncogene in Pancreatic Cancer to Regulate GPRC5A Expression by Targeting Transcription Factor KLF4

Overview

Journal Cell Death Discov

Date 2022 Jan 14

PMID 35027543

Authors

Daren Liu

Yun Jin

Jinhong Wu

Huanbing Zhu

Dan Ye

Affiliations

Soon will be listed here.

Abstract

KLF4 is implicated in tumor progression of pancreatic cancer, but the molecular regulatory mechanism of KLF4 needs to be further specified. We aimed to probe molecular regulatory mechanism of KLF4 in malignant progression of pancreatic cancer. qRT-PCR or western blot was completed to test levels of predicted genes. Dual-luciferase and chromatin immunoprecipitation (ChIP) assays were designed to validate binding between genes. Cell viability and oncogenicity detection were used for in vitro and vivo functional assessment. KLF4 was a downstream target of miR-135b-5p. KLF4 could regulate GPRC5A level. MiR-135b-5p was notably increased in cancer cells, and overexpressing KLF4 functioned a tumor repressive role, which could be restored by miR-135b-5p. Besides, cell malignant phenotypes could be inhibited through reducing miR-135b-5p level, but they were restored by GPRC5A. Our results stressed that KLF4, as a vital target of miR-135b-5p, could influence promoter region of GPRC5A, thus affecting the malignant progression of pancreatic cancer.

Citing Articles

KLF4: a multifunctional nexus connecting tumor progression and immune regulation.

Ju Y, Xiao W, Mathis B, Shi Y Front Immunol. 2025; 16:1514780.

PMID: 39995670 PMC: 11848521. DOI: 10.3389/fimmu.2025.1514780.

MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3.

Peng C, Li X, Yao Y, Nie Y, Fan L, Zhu C Cancer Biol Ther. 2024; 25(1):2373497.

PMID: 38967961 PMC: 11229718. DOI: 10.1080/15384047.2024.2373497.

LncRNA GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC.

Zhang J, You Q, Wang Y, Ji J Biologics. 2024; 18:129-142.

PMID: 38817552 PMC: 11137960. DOI: 10.2147/BTT.S454058.

The Role of Krüppel-like Factors in Pancreatic Physiology and Pathophysiology.

Giarrizzo M, LaComb J, Bialkowska A Int J Mol Sci. 2023; 24(10).

PMID: 37239940 PMC: 10218095. DOI: 10.3390/ijms24108589.

Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis.

Xin W, Fu Y, Chen L, Ding H, Feng T, Sun J J Gastrointest Oncol. 2023; 14(2):719-732.

PMID: 37201049 PMC: 10186514. DOI: 10.21037/jgo-23-192.

References

Ying H, Dey P, Yao W, Kimmelman A, Draetta G, Maitra A . Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2016; 30(4):355-85. PMC: 4762423. DOI: 10.1101/gad.275776.115. View

Ganguly K, Krishn S, Rachagani S, Jahan R, Shah A, Nallasamy P . Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. Cancer Res. 2020; 81(1):91-102. PMC: 7990052. DOI: 10.1158/0008-5472.CAN-20-1293. View

Lulli V, Buccarelli M, Martini M, Signore M, Biffoni M, Giannetti S . miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Oncotarget. 2015; 6(35):37241-56. PMC: 4741927. DOI: 10.18632/oncotarget.5925. View

Kamisawa T, Wood L, Itoi T, Takaori K . Pancreatic cancer. Lancet. 2016; 388(10039):73-85. DOI: 10.1016/S0140-6736(16)00141-0. View

Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q . KLF4α up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology. 2010; 139(6):2135-45. PMC: 3245983. DOI: 10.1053/j.gastro.2010.08.022. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

Hu W, Jia Y, Xiao X, Lv K, Chen Y, Wang L . KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth. Oncotarget. 2016; 7(33):52870-52887. PMC: 5288155. DOI: 10.18632/oncotarget.9141. View

Zhang L, Li X, Chao Y, He R, Liu J, Yuan Y . KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer. Cell Commun Signal. 2018; 16(1):53. PMC: 6122640. DOI: 10.1186/s12964-018-0270-x. View

Zhang Z, Che X, Yang N, Bai Z, Wu Y, Zhao L . miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. Biomed Pharmacother. 2017; 96:1341-1348. DOI: 10.1016/j.biopha.2017.11.074. View

10.

Yan Y, Li Z, Kong X, Jia Z, Zuo X, Gagea M . KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis. Cancer Res. 2016; 76(8):2419-31. PMC: 4876033. DOI: 10.1158/0008-5472.CAN-15-1691. View

11.

Farrugia M, Vanderbilt D, Salkeni M, Ruppert J . Kruppel-like Pluripotency Factors as Modulators of Cancer Cell Therapeutic Responses. Cancer Res. 2016; 76(7):1677-82. PMC: 4873413. DOI: 10.1158/0008-5472.CAN-15-1806. View

12.

Jia Y, Ying X, Zhou J, Chen Y, Luo X, Xie S . The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth. Cell Death Dis. 2018; 9(6):603. PMC: 5964121. DOI: 10.1038/s41419-018-0580-3. View

13.

Munding J, Adai A, Maghnouj A, Urbanik A, Zollner H, Liffers S . Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer. 2011; 131(2):E86-95. DOI: 10.1002/ijc.26466. View

14.

Yang L, Ma T, Zhang J . GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway. Oncol Rep. 2016; 36(5):2983-2990. DOI: 10.3892/or.2016.5062. View

15.

Ma Y, Wu L, Liu X, Xu Y, Shi W, Liang Y . KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling. Oncol Rep. 2017; 38(2):975-984. DOI: 10.3892/or.2017.5736. View

16.

Zhu Z, Yu Z, Wang J, Zhou L, Zhang J, Yao B . Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression. Cell Physiol Biochem. 2018; 46(1):238-252. DOI: 10.1159/000488426. View

17.

Li D, Peng Z, Tang H, Wei P, Kong X, Yan D . KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis. Clin Cancer Res. 2011; 17(11):3558-68. PMC: 3107880. DOI: 10.1158/1078-0432.CCR-10-2729. View

18.

Shen Y, Chen G, Gao H, Li Y, Zhuang L, Meng Z . miR-939-5p Contributes to the Migration and Invasion of Pancreatic Cancer by Targeting ARHGAP4. Onco Targets Ther. 2020; 13:389-399. PMC: 6969703. DOI: 10.2147/OTT.S227644. View

19.

Shi M, Cui J, du J, Wei D, Jia Z, Zhang J . A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer. Clin Cancer Res. 2014; 20(16):4370-80. PMC: 4134726. DOI: 10.1158/1078-0432.CCR-14-0186. View

20.

Sung M, Hsu H, Lee C, Lee H, Kuo Y, Hua K . Krüppel-like factor 4 modulates the migration and invasion of hepatoma cells by suppressing TIMP-1 and TIMP-2. Oncol Rep. 2015; 34(1):439-46. DOI: 10.3892/or.2015.3964. View